Suppr超能文献

儿童严重哮喘的特征是嗜酸性粒细胞增多和重塑,而没有 T(H)2 细胞因子。

Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines.

机构信息

the Royal Brompton and Harefield NHS Trust, London, UK.

出版信息

J Allergy Clin Immunol. 2012 Apr;129(4):974-82.e13. doi: 10.1016/j.jaci.2012.01.059. Epub 2012 Mar 3.

Abstract

BACKGROUND

The pathology of pediatric severe therapy-resistant asthma (STRA) is little understood.

OBJECTIVES

We hypothesized that STRA in children is characterized by airway eosinophilia and mast cell inflammation and is driven by the T(H)2 cytokines IL-4, IL-5, and IL-13.

METHODS

Sixty-nine children (mean age, 11.8 years; interquartile range, 5.6-17.3 years; patients with STRA, n = 53; control subjects, n = 16) underwent fiberoptic bronchoscopy, bronchoalveolar lavage (BAL), and endobronchial biopsy. Airway inflammation, remodeling, and BAL fluid and biopsy specimen T(H)2 cytokines were quantified. Children with STRA also underwent symptom assessment (Asthma Control Test), spirometry, exhaled nitric oxide and induced sputum evaluation.

RESULTS

Children with STRA had significantly increased BAL fluid and biopsy specimen eosinophil counts compared with those found in control subjects (BAL fluid, P < .001; biopsy specimen, P < .01); within the STRA group, there was marked between-patient variability in eosinophilia. Submucosal mast cell, neutrophil, and lymphocyte counts were similar in both groups. Reticular basement membrane thickness and airway smooth muscle were increased in patients with STRA compared with those found in control subjects (P < .0001 and P < .001, respectively). There was no increase in BAL fluid IL-4, IL-5, or IL-13 levels in patients with STRA compared with control subjects, and these cytokines were rarely detected in induced sputum. Biopsy IL-5(+) and IL-13(+) cell counts were also not higher in patients with STRA compared with those seen in control subjects. The subgroup (n = 15) of children with STRA with detectable BAL fluid T(H)2 cytokines had significantly lower lung function than those with undetectable BAL fluid T(H)2 cytokines.

CONCLUSIONS

STRA in children was characterized by remodeling and variable airway eosinophil counts. However, unlike in adults, there was no neutrophilia, and despite the wide range in eosinophil counts, the T(H)2 mediators that are thought to drive allergic asthma were mostly absent.

摘要

背景

儿科重症治疗抵抗性哮喘(STRA)的病理学尚不清楚。

目的

我们假设儿童 STRA 的特征是气道嗜酸性粒细胞增多和肥大细胞炎症,并由 T(H)2 细胞因子 IL-4、IL-5 和 IL-13 驱动。

方法

69 名儿童(平均年龄 11.8 岁;四分位间距 5.6-17.3 岁;STRA 患儿 53 例,对照组 16 例)行纤维支气管镜检查、支气管肺泡灌洗(BAL)和支气管内膜活检。定量检测气道炎症、重塑以及 BAL 液和活检标本中的 T(H)2 细胞因子。STRA 患儿还进行了症状评估(哮喘控制测试)、肺功能、呼出气一氧化氮和诱导痰评估。

结果

与对照组相比,STRA 患儿的 BAL 液和活检标本中的嗜酸性粒细胞计数明显增加(BAL 液,P <.001;活检标本,P <.01);在 STRA 组内,嗜酸性粒细胞增多存在显著的个体间变异性。两组的黏膜下肥大细胞、中性粒细胞和淋巴细胞计数无差异。与对照组相比,STRA 患儿的网状基底膜厚度和气道平滑肌均增加(P <.0001 和 P <.001)。与对照组相比,STRA 患儿的 BAL 液中 IL-4、IL-5 或 IL-13 水平无升高,且这些细胞因子在诱导痰中很少被检测到。与对照组相比,活检 IL-5(+)和 IL-13(+)细胞计数在 STRA 患儿中也没有升高。在可检测到 BAL 液 T(H)2 细胞因子的 STRA 患儿亚组(n = 15)中,肺功能明显低于无法检测到 BAL 液 T(H)2 细胞因子的患儿。

结论

儿童 STRA 的特征是重塑和气道嗜酸性粒细胞计数的可变性。然而,与成人不同,没有嗜中性粒细胞增多,尽管嗜酸性粒细胞计数范围广泛,但被认为驱动过敏性哮喘的 T(H)2 介质大多不存在。

相似文献

1
Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines.
J Allergy Clin Immunol. 2012 Apr;129(4):974-82.e13. doi: 10.1016/j.jaci.2012.01.059. Epub 2012 Mar 3.
2
IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma.
J Allergy Clin Immunol. 2013 Sep;132(3):676-685.e13. doi: 10.1016/j.jaci.2013.04.012. Epub 2013 Jun 4.
3
Intraepithelial neutrophils in pediatric severe asthma are associated with better lung function.
J Allergy Clin Immunol. 2017 Jun;139(6):1819-1829.e11. doi: 10.1016/j.jaci.2016.09.022. Epub 2016 Oct 13.
4
Blood eosinophil counts rarely reflect airway eosinophilia in children with severe asthma.
Allergy. 2013 Mar;68(3):402-6. doi: 10.1111/all.12101. Epub 2013 Jan 25.
5
Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests.
Am J Respir Crit Care Med. 2006 Dec 15;174(12):1286-91. doi: 10.1164/rccm.200603-352OC. Epub 2006 Sep 14.
8
Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms.
J Allergy Clin Immunol. 2015 Aug;136(2):323-33. doi: 10.1016/j.jaci.2015.01.014. Epub 2015 Mar 5.
9
Lung Lavage Granulocyte Patterns and Clinical Phenotypes in Children with Severe, Therapy-Resistant Asthma.
J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):1803-1812.e10. doi: 10.1016/j.jaip.2018.12.027. Epub 2019 Jan 14.

引用本文的文献

3
IL-33/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential.
Front Immunol. 2025 Jan 24;16:1533335. doi: 10.3389/fimmu.2025.1533335. eCollection 2025.
5
Evaluating Severe Therapy-Resistant Asthma in Children: Diagnostic and Therapeutic Strategies.
Medicina (Kaunas). 2024 Nov 2;60(11):1799. doi: 10.3390/medicina60111799.
7
Pediatric asthma comorbidities: Global impact and unmet needs.
World Allergy Organ J. 2024 May 22;17(5):100909. doi: 10.1016/j.waojou.2024.100909. eCollection 2024 May.
8
A murine model of peanut-allergic asthma.
Front Allergy. 2024 Apr 25;5:1378877. doi: 10.3389/falgy.2024.1378877. eCollection 2024.
10
The role of IL10 and IL17 gene polymorphisms in treatment response in children and adolescents with severe asthma.
J Bras Pneumol. 2024 Jan 15;49(6):e20230092. doi: 10.36416/1806-3756/e20230092. eCollection 2024.

本文引用的文献

1
Mechanisms controlling Th17 cytokine expression and host defense.
J Leukoc Biol. 2011 Aug;90(2):263-70. doi: 10.1189/jlb.0211099. Epub 2011 Apr 12.
2
Cytokine/anti-cytokine therapy - novel treatments for asthma?
Br J Pharmacol. 2011 May;163(1):81-95. doi: 10.1111/j.1476-5381.2011.01219.x.
3
IL-4 receptor α polymorphisms are predictors of a pharmacogenetic response to a novel IL-4/IL-13 antagonist.
J Allergy Clin Immunol. 2010 Oct;126(4):875-8. doi: 10.1016/j.jaci.2010.08.001.
4
Management of severe asthma in children.
Lancet. 2010 Sep 4;376(9743):814-25. doi: 10.1016/S0140-6736(10)61054-9.
5
Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes.
Ann Intern Med. 2010 Feb 16;152(4):232-7. doi: 10.7326/0003-4819-152-4-201002160-00008.
6
The importance of nurse-led home visits in the assessment of children with problematic asthma.
Arch Dis Child. 2009 Oct;94(10):780-4. doi: 10.1136/adc.2008.152140. Epub 2009 Jun 21.
7
Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma.
Eur Respir J. 2009 Nov;34(5):1052-9. doi: 10.1183/09031936.00186508. Epub 2009 Jun 18.
8
Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction.
J Allergy Clin Immunol. 2009 Jul;124(1):45-51.e1-4. doi: 10.1016/j.jaci.2009.03.049. Epub 2009 May 29.
9
Mepolizumab for difficult-to-control asthma with persistent sputum eosinophilia.
Expert Opin Investig Drugs. 2009 Jun;18(6):869-71. doi: 10.1517/13543780902922678.
10
Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.
N Engl J Med. 2009 Mar 5;360(10):985-93. doi: 10.1056/NEJMoa0805435.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验